Aintzane García‐Bea

738 total citations
16 papers, 261 citations indexed

About

Aintzane García‐Bea is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pathology and Forensic Medicine. According to data from OpenAlex, Aintzane García‐Bea has authored 16 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Aintzane García‐Bea's work include Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (5 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Aintzane García‐Bea is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Receptor Mechanisms and Signaling (5 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). Aintzane García‐Bea collaborates with scholars based in Spain, United States and United Kingdom. Aintzane García‐Bea's co-authors include Patrícia Miranda-Azpiazu, Javier González‐Maeso, J. Javier Meana, Luís F. Callado, José L. Moreno, Alexey Kozlenkov, Carolina Muguruza, Cristina Campo, Rebeca Dı́ez-Alarcia and Juan F. López‐Giménez and has published in prestigious journals such as Nutrients, Molecular Pharmacology and European Journal of Medicinal Chemistry.

In The Last Decade

Aintzane García‐Bea

15 papers receiving 257 citations

Peers

Countries citing papers authored by Aintzane García‐Bea

Since Specialization

Citations

This map shows the geographic impact of Aintzane García‐Bea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aintzane García‐Bea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aintzane García‐Bea more than expected).

Fields of papers citing papers by Aintzane García‐Bea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aintzane García‐Bea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aintzane García‐Bea. The network helps show where Aintzane García‐Bea may publish in the future.

Co-authorship network of co-authors of Aintzane García‐Bea

This figure shows the co-authorship network connecting the top 25 collaborators of Aintzane García‐Bea. A scholar is included among the top collaborators of Aintzane García‐Bea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aintzane García‐Bea. Aintzane García‐Bea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	A Randomized Phase II/III Trial Evaluating the Efficacy and Safety of 100 and 125 µg of Calcifediol Weekly Treatment of Severe Vitamin D Deficiency 2025 ·Nutrients ·José-Luis Pérez-Castrillón, Esteban Jódar, Ján Nociar, (unknown), Dimitar B. Nikolov, (unknown), (unknown), Umberto Tarantino, Nadia Mehsen-Cêtre, (unknown), (unknown), Aintzane García‐Bea, Inmaculada Gilaberte	0
2	Efficacy and Safety of Weekly Calcifediol Formulations (75 and 100 µg) in Subjects with Vitamin D Deficiency: A Phase II/III Randomised Trial 2024 ·Nutrients ·Esteban Jódar, José-Luis Pérez-Castrillón, Ján Nociar, (unknown), Dimitar B. Nikolov, (unknown), (unknown), Umberto Tarantino, Nadia Mehsen-Cêtre, (unknown), (unknown), Aintzane García‐Bea, Inmaculada Gilaberte	1
3	Opposite alterations of 5HT2A receptor brain density in subjects with schizophrenia: relevance of radiotracers pharmacological profile 2021 ·Translational Psychiatry ·Rebeca Dı́ez-Alarcia, Carolina Muguruza, Guadalupe Rivero, Aintzane García‐Bea, Vanessa Gómez‐Vallejo, Luís F. Callado, Jordi Llop, Abraham Martín, J. Javier Meana	15
4	Application of a dual mechanistic approach to support bilastine dose selection for older adults 2021 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), (unknown), Mónica Rodríguez, John C. Lukas, (unknown), Cristina Campo, Aintzane García‐Bea, Elena Suárez, Stephan Schmidt, Valvanera Vozmediano	10
5	Di-aryl guanidinium derivatives: Towards improved α2-Adrenergic affinity and antagonist activity 2020 ·European Journal of Medicinal Chemistry ·(unknown), Brendan Kelly, (unknown), (unknown), Fernando Rodrı́guez, (unknown), Aintzane García‐Bea, Patrícia Miranda-Azpiazu, Luís F. Callado, Isabel Rozas	4
6	Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria 2020 ·European Journal of Pediatrics ·Mónica Rodríguez, Valvanera Vozmediano, Aintzane García‐Bea, Zoltán Novàk, Anahí Yáñez, Cristina Campo, Luis Labeaga	12
7	Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: Selective biased agonism via Gαi1-proteins 2019 ·European Neuropsychopharmacology ·Aintzane García‐Bea, Patrícia Miranda-Azpiazu, Carolina Muguruza, (unknown), Rebeca Dı́ez-Alarcia, Ane M. Gabilondo, Luís F. Callado, Benito Morentín, Javier González‐Maeso, J. Javier Meana	38
8	Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study 2019 ·European Journal of Drug Metabolism and Pharmacokinetics ·Belén Sádaba, José Ramón Azanza Perea, Aintzane García‐Bea, Luis Labeaga, Cristina Campo, Román Valiente	5
9	Efficacy and safety of bilastine in reducing pruritus in patients with chronic spontaneous urticaria and other skin diseases: an exploratory study 2019 ·Journal of Dermatological Treatment ·(unknown), Cristina Campo, Zoltán Novàk, Bernadetta Majorek‐Olechowska, Grażyna Pulka, Aintzane García‐Bea, Luis Labeaga	17
10	A group II metabotropic glutamate receptor 3 (mGlu3, GRM3) isoform implicated in schizophrenia interacts with canonical mGlu3 and reduces ligand binding 2017 ·Journal of Psychopharmacology ·Aintzane García‐Bea, Isabel Bermúdez, Paul J. Harrison, Tracy Lane	8
11	Substituted conformationally restricted guanidine derivatives: Probing the α2-adrenoceptors’ binding pocket 2016 ·European Journal of Medicinal Chemistry ·(unknown), Aintzane García‐Bea, Patrícia Miranda-Azpiazu, Luís F. Callado, Isabel Rozas	15
12	Metabotropic glutamate receptor 3 (mGlu3; mGluR3; GRM3) in schizophrenia: Antibody characterisation and a semi-quantitative western blot study 2016 ·Schizophrenia Research ·Aintzane García‐Bea, Mary A. Walker, Thomas M. Hyde, Joel E. Kleinman, Paul J. Harrison, Tracy Lane	19
13	Allosteric signaling through an mGlu2 and 5-HT_2Aheteromeric receptor complex and its potential contribution to schizophrenia 2016 ·Science Signaling ·José L. Moreno, Patrícia Miranda-Azpiazu, Aintzane García‐Bea, (unknown), Meng Cui, Alexey Kozlenkov, (unknown), Georgios Voloudakis, Amanda K. Fakira, Lia Baki, Yongchao Ge, Anastasios Georgakopoulos, José A. Morón, Graeme Milligan, Juan F. López‐Giménez, Nikolaos K. Robakis, Diomedes E. Logothetis, J. Javier Meana, Javier González‐Maeso	88
14	P.3.a.001 Selective up-regulation of serotonin 5-HT2A receptor coupling to Gαi1-proteins in postmortem brain of subjects with schizophrenia 2014 ·European Neuropsychopharmacology ·J. Javier Meana, Patrícia Miranda-Azpiazu, Aintzane García‐Bea, Carolina Muguruza, Luís F. Callado, Ane M. Gabilondo, Rebeca Dı́ez-Alarcia, Javier González‐Maeso	1
15	Repressive Epigenetic Changes at the mGlu2 Promoter in Frontal Cortex of 5-HT2A Knockout Mice 2013 ·Molecular Pharmacology ·Mitsumasa Kurita, José L. Moreno, Terrell Holloway, Alexey Kozlenkov, Giuseppe Mocci, Aintzane García‐Bea, James B. Hanks, Rachael L. Neve, Eric J. Nestler, Scott J. Russo, Javier González‐Maeso	25
16	P.1.g.022 Hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists induce distinct patterns of G protein coupling in postmortem human brain 2013 ·European Neuropsychopharmacology ·Patrícia Miranda-Azpiazu, Rebeca Dı́ez-Alarcia, Aintzane García‐Bea, Javier González‐Maeso, Benito Morentín, J. Javier Meana	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact